These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7699066)

  • 21. [Typing and sensitivity of meningococci isolated in Switzerland 1988-1990].
    Rohner P; Pepey B; Hirschel B; Auckenthaler R
    Schweiz Med Wochenschr; 1992 Feb; 122(7):224-8. PubMed ID: 1539123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37.
    Krízová P; Musílek M; Kalmusová J
    Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annual report of the Australian Meningococcal Surveillance Programme, 2002.
    Australian Meningococcal Surveillance Programme
    Commun Dis Intell Q Rep; 2003; 27(2):196-208. PubMed ID: 12926735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neisseria meningitidis strains isolated from patients].
    Berger U
    Zentralbl Bakteriol Orig; 1968; 207(3):290-303. PubMed ID: 4317556
    [No Abstract]   [Full Text] [Related]  

  • 25. Australian Meningococcal Surveillance Programme annual report, 2019.
    Lahra MM; Hogan TR;
    Commun Dis Intell (2018); 2020 Aug; 44():. PubMed ID: 32829701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile.
    Cruz C; Pavez G; Aguilar E; Grawe L; Cam J; Mendez F; Garcia J; Ruiz S; Vicent P; Canepa I
    Epidemiol Infect; 1990 Aug; 105(1):119-26. PubMed ID: 2116973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Neisseria meningitidis isolates and clinical features of meningococcal conjunctivitis in ten patients.
    Anderson J; Lind I
    Eur J Clin Microbiol Infect Dis; 1994 May; 13(5):388-93. PubMed ID: 8070451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neisseria meningitidis disease-associated clones in Amazonas State, Brazil.
    Silva LA; Coronato B; Schlackman J; Marsh JW; Ezeonwuka C; Fernandes ACL; Souza VC; da Silva LS; de Amorim EFQ; Naveca FG; de Albuquerque BC; Amaral A; Souza ALS; Carvalho-Costa FA; Mustapha MM; Harrison LH; Barroso DE
    Infect Dis (Lond); 2018 Sep; 50(9):697-704. PubMed ID: 29623748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of a collection of Neisseria meningitidis isolates from Croatia, June 2009 to January 2014.
    Bukovski S; Vacca P; Anselmo A; Knezovic I; Fazio C; Neri A; Ciammaruconi A; Fortunato A; Palozzi AM; Fillo S; Lista F; Stefanelli P
    J Med Microbiol; 2016 Sep; 65(9):1013-1019. PubMed ID: 27452726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada.
    Tsang RS; Tsai CM; Zhu P; Ringuette L; Lorange M; Law DK
    J Clin Microbiol; 2004 Apr; 42(4):1460-5. PubMed ID: 15070989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain).
    Martínez AI; Dominguez A; Oviedo M; Minguell S; Jansa JM; Codina G; Vazquez JA;
    Vaccine; 2009 May; 27(25-26):3496-8. PubMed ID: 19200816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serogroups, serotypes, serosubtypes and antimicrobial susceptibility of Neisseria meningitidis isolates in Casablanca, Morocco.
    Zerouali K; Elmdaghri N; Boudouma M; Benbachir M
    Eur J Clin Microbiol Infect Dis; 2002 Jun; 21(6):483-5. PubMed ID: 12111610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annual report of the Australian Meningococcal Surveillance Programme, 1997.
    Commun Dis Intell; 1998 Oct; 22(10):205-11. PubMed ID: 9803595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Australian Meningococcal Surveillance Programme annual report, 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E503-E511. PubMed ID: 28043225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Phenotyping and antibiotic susceptibility's study of Neisseria meningitidis strains isolated at the "Hôpital d'Enfants" of Tunis].
    Saguer A; Smaoui H; Kechrid A
    Tunis Med; 2006 Nov; 84(11):730-3. PubMed ID: 17294901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of Neisseria meningitidis strains from the civilian population to sulfadiazine, penicillin, and rifampin.
    Wiggins GL; McLaughlin JV; Bickham ST; Jones WL; Balows A
    Appl Microbiol; 1970 Dec; 20(6):893-8. PubMed ID: 4992654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annual report of the Australian Meningococcal Surveillance Programme, 2004.
    Austarlian Meningococcal Surveillance Programme
    Commun Dis Intell Q Rep; 2005; 29(2):150-9. PubMed ID: 16119763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and serogroup changes of Neisseria meningitidis in South Korea, 2010-2016.
    Lee H; Seo Y; Kim KH; Lee K; Choe KW
    Sci Rep; 2018 Mar; 8(1):5292. PubMed ID: 29593277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971-1999.
    Hansman D; Wati S; Lawrence A; Turnidge J
    Pathology; 2004 Apr; 36(2):160-5. PubMed ID: 15203752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the use of mass chemoprophylaxis during a school outbreak of enzyme type 5 serogroup B meningococcal disease.
    Jackson LA; Alexander ER; DeBolt CA; Swenson PD; Boase J; McDowell MG; Reeves MW; Wenger JD
    Pediatr Infect Dis J; 1996 Nov; 15(11):992-8. PubMed ID: 8933547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.